Trending

Shilpa Medicare gets nod for Phase III clinical trials of Human Albumin

Image

Shilpa Medicare has informed that the Subject Expert Committee (Haematology) (SEC) has accepted the results of its Phase I clinical trials for Recombinant Human Albumin (rHA) 20% and granted approval to proceed with Phase III clinical trials.

You Might Also Like...

Sign Up for Our Newsletter

Subscribe now to get notified about exclusive offers
from The .... every week!